Drug Science Reports that Medical Cannabis Improves Quality of Life by Over 50% - Preliminary Results
The UK’s largest-ever medical cannabis patient study, by Drug Science's Project21, has published it's first findings suggesting that medical cannabis improves quality of life.
900+ patients that have received licensed prescriptions for medical cannabis agreed for their medical data to be collected and analysed.
The EQ-5D-5L rating of quality of life was used. Preliminary data found:
- A 51% increase in patients’ self-reported health and ability to lead a more normal life, demonstrated by an average increase from 40.7 to 61.5 after 3 months
- Significant improvements in patients’ ability to manage debilitating secondary conditions such as anxiety, insomnia and depression
- Patients are now able to avoid criminality with legal prescriptions. 63% had previously felt compelled to turn to illegal use in an attempt to manage their conditions
- Medical Cannabis prescriptions provide a welcome alternative to commonly prescribed medicines that have a high risk of dependency and serious side effects, including dependency
- Legally prescribed medical cannabis improves quality of life and provides clinically significant improvements in the quality of life of patients living with conditions such as Chronic Pain, Multiple Sclerosis, Tourette’s Syndrome, Epilepsy, and Post Traumatic Stress Disorder (PTSD)
For more updates on the latest psychedelic news and research, visit the psychedelic health professional network homepage.